Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Eliquis3.42B28.00%
Opdivo2.39B19.56%
Revlimid1.35B11.09%
Other1.32B10.80%
Pomalyst/Imnovid959M7.86%
Orencia948M7.77%
Yervoy630M5.16%
Reblozyl425M3.48%
Sprycel424M3.48%
Other Growth products341M2.79%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States31.56B70.11%
International12.75B28.33%
Other699M1.55%
